Godcare Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -59.47%
- Profit Growth 42.64%
- Ebitda 78.74%
- Net Worth -11.13%
- Total Assets 16.37%
About Godcare Pharma
Godcare Pharma Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 January 2020 (Five years and one month 10 days old ). Its registered office is in Gorakhpur, Uttar Pradesh, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Devendra Shukla and Sunit Shukla serve as directors at the Company.
Company Details
- Location
Gorakhpur, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231UP2020PTC125691
- Company No.
125691
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jan 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Godcare Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devendra Shukla  | Director | 14-Jan-2020 | Current |
| Sunit Shukla | Director | 16-May-2022 | Current |
Financial Performance of Godcare Pharma.
Godcare Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 59.47% decrease. The company also saw a substantial improvement in profitability, with a 42.64% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Godcare Pharma?
Unlock access to Godcare Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Mucosis Life Sciences Private LimitedDevendra Shukla and Sunit Shukla are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Godcare Pharma?
Unlock and access historical data on people associated with Godcare Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Godcare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Godcare Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
